Cavagnero, 1990 - Google Patents
Structure-activity studies of delta-selective opioid analoguesCavagnero, 1990
View PDF- Document ID
- 1837703175676958395
- Author
- Cavagnero S
- Publication year
External Links
Snippet
dissertation copies are in typewriter face, while others may be from any Page 1 INFORMATION
TO) USERS The most advanced technology has been used to photograph and reproduce this
manuscript from the microfilm master. UMI films the text directly from the original or copy …
- 230000000694 effects 0 title description 19
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schiller et al. | Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analog: effects on receptor selectivity and stereospecificity | |
CA2223176C (en) | Novel kappa receptor selective opioid peptides | |
Schiller et al. | Cyclic enkephalin analogs containing a cystine bridge | |
Dooley et al. | Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries. | |
US20060240481A1 (en) | Melanocortin Metallopeptode Combinatorial Libraries and Applications | |
EP1208377A1 (en) | Melanocortin metallopeptide constructs, combinatorial libraries and applications | |
Balboni et al. | Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei | |
McFadyen et al. | Tetrapeptide derivatives of [D-Pen2, D-Pen5]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the μ-opioid receptor | |
Cavagnero | Structure-activity studies of delta-selective opioid analogues | |
Jastrzȩbska et al. | Influence of 1‐aminocyclohexane‐1‐carboxylic acid in position 2 or 3 of AVP and its analogues on their pharmacological properties | |
Cavagnero et al. | Delta opioid receptor-selective ligands:[] enkephalin-dermenkephalin-dermenkephalin chimeric peptides | |
EP0853484A1 (en) | Novel mu opioid receptor ligands: agonists and antagonists | |
Guerrini et al. | Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity | |
Weltrowska et al. | N‐Methylated cyclic enkephalin analogues retain high opioid receptor binding affinity | |
Bélec et al. | The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine6‐oxytocin and penicillamine6‐5‐tert‐butylproline7‐oxytocin analogs | |
US20050181447A1 (en) | Opioid metallopeptide compositions and methods | |
Schullery et al. | The role of backbone conformation in deltorphin II binding: A QSAR study of new analogues modified in the 5-, 6-positions of the address domain | |
Day et al. | Synthesis of an intrinsically radiolabeled enkephalin analog:[p‐tritio‐phenylalanyl] 4‐norleucyl5‐enkephalin | |
Ho | Development of a model for the mu opioid receptor pharmacophore | |
Kutralanathan | Aromatic amino acid replacement at the N-terminus of a nonselective opioid deltorphin analog: A QSAR study | |
Łempicka et al. | Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments | |
Vig | Synthesis and pharmacological evaluation of dynorphin A analogs constrained in the “message” sequence | |
Landis | Synthesis and biological activities of tachykinin and opioid-related compounds, synthesis of unusual amino acids, and the investigations into the smooth muscle pharmacology of tachykinins | |
Heyl et al. | Structural requirements for binding to the δ opioid receptor: Alkyl replacements at the third residue of deltorphin I | |
Kazmierski | Synthesis and hydrogen-1 NMR conformational analysis of potent and mu opioid receptor selective cyclic peptides: Topographical design utilizing a conformationally stable template |